Literature DB >> 2704926

Economic benefits of an effective infection control program: case study and proposal.

P J Miller1, B M Farr, J M Gwaltney.   

Abstract

An economic model of the 981 nosocomial infections that occurred in 1985 at the University of Virginia Medical Center was developed. It was determined that $2,401,709 in excess charges and $2,111,753 in excess variable costs were saved in 1985 as a result of having an effective infection control program in place. If a nominal per diem patient fee ($5) were billed to each patient or third-party carrier for preventive services rendered by the infection control team and channeled to infection control for the 196,141 patient-days in 1985, income of $980,705 would have been generated, leaving net income of $812,979 after the deduction of infection control operating costs. In addition, patients, third-party payers, and the hospital would have still saved $1,421,004 in excess charges, or $1,131,048 in excess variable costs, in prevented infections. Infection control programs are extremely cost effective, and if preventive care is to be encouraged, financial incentives for value received for infection control services are needed.

Entities:  

Mesh:

Year:  1989        PMID: 2704926     DOI: 10.1093/clinids/11.2.284

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  4 in total

Review 1.  Treatment of urinary tract infection. Clinical and economic considerations.

Authors:  R J Plumridge; C L Golledge
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

2.  Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.

Authors:  John C Woodfield; Andre M Van Rij; Ross A Pettigrew; Antje van der Linden; Donna Bolt
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

3.  Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit.

Authors:  I Kappstein; G Schulgen; U Beyer; K Geiger; M Schumacher; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

4.  Infection control and prevention strategies in the ICU.

Authors:  A F Widmer
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.